The market was valued at $101 billion in 2013 and is expected to grow at a compound annual growth rate of 7.6 percent from 2014 to 2020.
The market includes the following segments: tumor marker tests, imaging modalities, endoscopies and biopsies. It is expected that the global market for cancer imaging diagnosis will grow at a CAGR of 8.2 percent from 2014 to 2020.
North America is the dominant regional market for cancer diagnostics with a share of approximately 40.7 percent of the overall cancer diagnostics market in terms of revenue in 2013. However, the changing regulatory scenario among the high-growth countries in the Asia Pacific is also attracting leading companies in the cancer diagnostics market, according to the report.
More articles on gastroenterology:
Cantel Medical names Jorgen Hansen president, COO
Hanover Gastroenterology expands
GI physician to know: Dr. David Rubin of University of Chicago Medicine
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.